Monte Rosa Therapeutics
GLUE
#6650
Rank
NZ$0.87 B
Marketcap
$14.31
Share price
-0.12%
Change (1 day)
190.69%
Change (1 year)

Market capitalization of Monte Rosa Therapeutics (GLUE)

Market cap: NZ$0.87 Billion

As of November 2024 Monte Rosa Therapeutics has a market cap of NZ$0.87 Billion. This makes Monte Rosa Therapeutics the world's 6650th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Monte Rosa Therapeutics from 2021 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$0.87 B96.47%
2023NZ$0.44 B-22.87%
2022NZ$0.58 B-58.27%
2021NZ$1.39 B

End of Day market cap according to different sources

On Nov 21st, 2024 the market cap of Monte Rosa Therapeutics was reported to be:

NZ$0.88 Billion
by Nasdaq info icon info icon
NZ$0.87 Billion
by CompaniesMarketCap info icon info icon